Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Neurological disorders are diseases of the brain, spine and the nerves that connect them. There are more than 600 diseases of the nervous system, such as brain tumors, epilepsy, Parkinson's disease and stroke as well as less familiar ones such as frontotemporal dementia. Many bacterial, viral, and parasitic infections can affect the nervous system. Neurological disorders are a growing and serious problem in many parts of the world. Hundreds of millions of people worldwide are affected by neurological disorders. According to the World Health Organisation data, Approximately 6.2 million people die from stroke each year, more than 80% in low- and middle-income countries. Further, over 50 million people have epilepsy worldwide. More than 50 million people worldwide suffer from epilepsy and it is estimated that 47.5 million people suffer from dementia, with 7.7 million new cases each year -Alzheimer's disease being the most involved prevalent dementia. The global prevalence of migraine is greater than 10%.
Major factors driving the growth neurology devices market include Significant rise in the prevalence of neurological diseases, severity of the disease, favourable medical reimbursements, ongoing product development & commercialization, surge in demand for minimally invasive procedures coupled with the expansion of healthcare infrastructure across emerging markets. Further, as the global population of the elderly continues to rise, there has been a parallel rise in the awareness levels pertaining to neurological diseases. As a result, the demand for neurological devices that are used in treating such disorders has seen an upward growth trend. Moreover, mounting number of researches in the field of neurovascular therapies and growing awareness among neurosurgeons about minimally invasive surgical procedures provide significant growth opportunities in the market. However, stringent regulatory scenario and high cost of procedures policies are expected to restrain the market during the forecast period.
The report analyses the neurology devices market based on product and geography.
The various neurology devices commercially available in the market for the treatment of the various neurological disorders include neurostimulation, interventional neurology, CSF management, and neurosurgery devices. Further classification of neurostimulation devices includes spinal cord stimulation, spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation and gastric electric stimulation. Interventional neurology products consists of aneurysm coiling and embolization, neurovascular catheters, cerebral balloon angioplasty &stents. Further, aneurysm coiling and embolization devices are accessible as embolic coils (bare detachable coils and coated detachable coils), flow diversion devices, and liquid embolic reagents. Neurovascular catheters comprises of micro catheters and micro guidewires. Also, cerebral balloon angioplasty &stents consist of carotid artery stents and embolic protection systems (distal filter devices and balloon occlusion devices). Whereas, neurothromobectomy devices include clot retrievers, suction aspiration devices and snare devices. Moreover, CSF management devices are accessible as cerebral shunts and cerebral external drainage. Neurosurgery devices comprises ultrasonic aspirators, stereotactic systems, neuroendoscopes and aneurysm clips.
Neurostimulation devices are commonly used mainly for the treatment of neurologic disorders that aid in the delivery of electrical stimulation to intended parts of the patient’s brain, peripheral nervous system, and spinal cord for the treatment of various disorders such as movement disorders, epilepsy, Parkinson’s disease, chronic pain, depression, among other diseases. Neurostimulation devices account for significant market share as the segment is vital for treatment of various disorders including loco motor and nervous disorders.
The global study conducted neurology devices vertical to estimate and forecast revenue of the various products and distribution channel across the countries of key regions of North America, Europe, APAC and rest of the world regions. North America held the highest market share in the neurology devices market owing to the presence of sophisticated healthcare infrastructure, neurological R&D investment, and the presence of a considerably large CNS disorder patient base are some drivers of this market. The availability of medical reimbursements for neurovascular treatment procedures is continuously increasing among mature markets such as the US which will further develop the growth of the market.
Asia Pacific is expected to witness lucrative CAGR over a forecast 2020-2025 due to the presence of high unmet medical needs, coupled with rapidly rising healthcare R&D investments and growing medical expenditures in emerging economies, such as India and China. Moreover, supportive government initiatives pertaining to increasing investments by manufacturers and high untapped market opportunities are the important factors aatributed to the high growth of the market in this region.
January 2018: Medtronic received US FDA clearance for Riptide aspiration system intended for use in the revascularization of patients with acute ischaemic stroke secondary to large intracranial vessel occlusive disease
July 2017: Johnson & Johnson Medical Devices Companies recently introduced CERENOVUS, its new neurovascular business.
Some of the major players opening in this region include B. Braun Melsungen AG, Covidien PLC, Integra LifeSciences Holdings Corporation, Johnson and Johnson, St. Jude Medical, Inc, Stryker Corporation, Magstim Co Ltd., Stryker, Corporation, Medtronic PLC, Johnson & Johnson, Terumo Corporation, Penumbra, Inc., Boston Scientific Corporation, Microport Scientific Corporation, Merit Medical Systems, Inc., W.L. Gore & Associates, Inc., Abbott Laboratories among others.
The report analyses the Neurology Devices Market based on product, and geography. The various neurology devices commercially available in the market for the treatment of the various neurological disorders include neurostimulation, interventional neurology, CSF management, and neurosurgery devices. Further classification of neurostimulation devices includes spinal cord stimulation, spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation and gastric electric stimulation. Interventional neurology products consists of aneurysm coiling and embolization, neurovascular catheters, cerebral balloon angioplasty &stents. Further, aneurysm coiling and embolization devices are accessible as embolic coils (bare detachable coils and coated detachable coils), flow diversion devices, and liquid embolic reagents. Neurovascular catheters comprises of micro catheters and micro guidewires. Also, cerebral balloon angioplasty &stents consist of carotid artery stents and embolic protection systems (distal filter devices and balloon occlusion devices). Whereas, neurothromobectomy devices include clot retrievers, suction aspiration devices and snare devices. Moreover, CSF management devices are accessible as cerebral shunts and cerebral external drainage. Neurosurgery devices comprises ultrasonic aspirators, stereotactic systems, neuroendoscopes and aneurysm clips. The global study conducted neurology devices vertical to estimate and forecast revenue of the various products and distribution channel across the countries of key regions of North America, Europe, APAC and rest of the world regions.
Some of the major players opening in this region include B. Braun Melsungen AG, Covidien PLC, Integra LifeSciences Holdings Corporation, Johnson and Johnson, St. Jude Medical, Inc, Stryker Corporation, Magstim Co Ltd., Stryker, Corporation, Medtronic PLC, Johnson & Johnson, Terumo Corporation, Penumbra, Inc., Boston Scientific Corporation, Microport Scientific Corporation, Merit Medical Systems, Inc., W.L. Gore & Associates, Inc., Abbott Laboratories among others.
Why to buy this report:
